Hippotherapy to Improve the Balance of Children With Movement Disorders (HPOT)

This study has been completed.
Sponsor:
Information provided by:
Central Michigan University
ClinicalTrials.gov Identifier:
NCT01313325
First received: March 9, 2011
Last updated: March 10, 2011
Last verified: March 2011

March 9, 2011
March 10, 2011
September 2006
December 2007   (final data collection date for primary outcome measure)
Pediatric Balance Scale [ Time Frame: 8-9 weeks ] [ Designated as safety issue: No ]
The Pediatric Balance Scale (PBS) is a standardized 14 item test of various component activities related to balance. It is a modified child version of the adult Berg Balance Scale. The PBS has high total score test-retest reliability of ICC (3,1) =0.998, as well as good interrater reliability (ICC(3,1) = 0.997).1
Same as current
Complete list of historical versions of study NCT01313325 on ClinicalTrials.gov Archive Site
Activities Scale for Kids [ Time Frame: 8-9 weeks ] [ Designated as safety issue: No ]
Activities Scale for Kids - Participation (ASKp) is a self-administered 30 item questionaire that measures the impact of children's disability to overall function and participation within relevant environments. It correlates well with parent reports on the Childhood Health Assessment Questionnaire (r=0.81, p<0.000) and clinician observations of children's function (ICC=0.92, p<0.000).
Same as current
Not Provided
Not Provided
 
Hippotherapy to Improve the Balance of Children With Movement Disorders
Hippotherapy to Improve Balance Deficits in a Cohort of Children With Movement Disorders: A Pilot Study

The purpose of this study is to determine if adding hippotherapy treatment will improve balance for children ages 5-17 who have disabilities such as cerebral palsy and down syndrome. We also want to find out if by improving their balance the children increase their participation in age appropriate activities.

The primary purpose of this study is to determine the effects of hippotherapy on the balance of children with developmental disorders that cause mild to moderate balance problems. The secondary purpose is to determine if the use of hippotherapy also improves perceived functional abilities and thus quality of life as measured by the pediatric balance scale and Activities Scale for Kids (respectively)

Interventional
Not Provided
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
  • Neuromuscular Diseases
  • Cerebral Palsy
  • Down Syndrome
  • Autism
  • Developmental Coordination Disorder
Other: Hippotherapy
Children will receive treatment by a licensed physical therapist using hippotherapy as the treatment strategy. This includes sitting on a horse who's movement is controlled by a horse leader, with the PT directing the movements required of the horse, as well as supplying supplemental cues to the participant. Alternative positions (such as sitting backward and sideways) may also be used during the treatment session.
Experimental: Treatment group
Children between 5-17 years who have balance deficits related to any movement disorder (preferably neuromuscular)
Intervention: Other: Hippotherapy

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
16
December 2007
December 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • between the ages of 5 and 17
  • have a neuromuscular diagnosis or confirmed difficulties with balance
  • be able to stand 4 seconds without an assistive device
  • be able to follow testing instructions
  • must be under 250 pounds
  • be able to attend a minimum 10/12 sessions.

Exclusion Criteria:

  • any compounding orthopedic or medical condition not related to the primary developmental diagnosis.
  • previous hippotherapy intervention or therapeutic riding experience
  • allergies or aversion to horses.
  • refusal of parents to sign the therapeutic riding center's liability release form
  • any new treatments (includes therapies, drugs, or other complementary treatments) within one month of the start of the study or plans for new treatments during the intervention period
  • lack of a physician referral for physical therapy
Both
5 Years to 17 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01313325
09/14/2006
No
Dr. Debbie Silkwood-Sherer, Central Michigan University
Central Michigan University
Not Provided
Principal Investigator: Debbie J Silkwood-Sherer, PT, DHS Central Michigan University
Central Michigan University
March 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP